Skip Navigation



Rheumatology Advance Access published online on March 5, 2009
Rheumatology, doi:10.1093/rheumatology/kep035
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
48/5/591    most recent
kep035v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chinoy, H.
Right arrow Articles by Cooper, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinoy, H.
Right arrow Articles by Cooper, R. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Clinical, serological and HLA profiles in non-Caucasian UK idiopathic inflammatory myopathy

Hector Chinoy1,2, Fiona Salway1, Noreen Fertig3, Chester V. Oddis3, William E. Ollier1 and Robert G. Cooper2

1Centre for Integrated Genomic Medical Research, The University of Manchester, 2The University of Manchester Rheumatic Diseases Centre, Salford Royal NHS Foundation Trust, Salford, UK and 3Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, USA on behalf of the UK Adult Onset Myositis Immunogenetic Collaboration

Correspondence to: Robert G. Cooper, The University of Manchester Rheumatic Diseases Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford M6 8HD, UK. E-mail: robert.g.cooper@manchester.ac.uk

The first 10% of the full text of this article appears below.

SIR, Since 2000, the UK Adult Onset Myositis Immunogenetic Collaboration (AOMIC) has recruited idiopathic inflammatory myopathy (IIM) cases across the UK. In this brief report, we summarize the clinical, serological and HLA Class II status of non-Caucasian IIM cases, to ascertain whether differences are observed among UK IIM ethnic populations.

DNA was available from 28 UK non-Caucasian IIM cases. Adult IIM patients, aged >=18 years of age at disease onset, with probable or definite myositis [1] were recruited through AOMIC . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?